Myocardial reperfusion is a critical aspect of cardiovascular health, representing the restoration of blood flow to the heart muscle after a period of ischemia. Ischemia occurs when blood supply to the heart is temporarily reduced or blocked, often during a heart attack. Reperfusion aims to alleviate this condition and minimize damage to the heart tissue. However, the process itself can induce injury due to the sudden reintroduction of oxygen, leading to oxidative stress and inflammation. Researchers and healthcare professionals are continually exploring innovative strategies to optimize myocardial reperfusion, with a focus on minimizing adverse effects and enhancing overall cardiac recovery. Understanding the intricacies of myocardial reperfusion is crucial in advancing therapeutic approaches for cardiovascular diseases and improving patient outcomes.
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain
Title : Innovative mechanisms, consequences and therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Comprehensive surgical revascularization for rapidly worsening ischemic heart failure
Deepak Puri, Max Healthcare, India